ProShares Pet Care ETF PAWZ CBOE · Financials · United States
$53.52 -2.74% -$1.51
Summary
ProShares Pet Care ETF is an ETF - a fund traded on an exchange like a stock - run by ProShares. Positions inside: 28. The ten largest make up 72% of the fund.
- Yearly costs
- 0.50%
- Fund size
- $34.8M
- Positions
- 28
- Dividend yield
- 0.68%
- Running since
- 2018
What speaks for it
Nothing stands out in its favour.
What to watch
- The ten largest positions make up 72% of the fund, so its result rests on a few names.
- 45% of the fund is in one sector (Healthcare).
- Costs of 0.50% a year are above the middle of comparable funds (0.45%).
- In the last five years its price once dropped by 51% from its high.
- A small fund with $34.8M under management; small funds get closed more often.
- It trades little: only about $110.1K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- +6.9%
- 3 months
- +4.4%
- This year
- +0.7%
- 1 year
- +5.1%
- 3 years
- +17%
- 5 years
- -32%
- Avg. market cap
- $42.4B
- P/E
- 26.3x
- Forward P/E
- 22.0x
- P/S
- 0.6x
- P/B
- 3.7x
- P/FCF
- 15.4x
- EV/EBITDA
- 14.4x
- Dividend yield
- 0.76%
- ROIC
- 4.7%
- ROE
- 33.0%
- Gross margin
- 46.5%
- Operating margin
- 13.6%
- Net margin
- 9.8%
- Payout ratio
- 20.0%
- Net debt/EBITDA
- 1.4x
- Beta
- 1.02
Weighted average of the 18 largest companies, which make up 71% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 IDIDEXX Laboratories IDXX 12%
- 2 CHChewy CHWY 10%
- 3 ZTZoetis ZTS 9.7%
- 4 FRFreshpet, Inc. FRPT 9.1%
- 5 VIRBAC SA 7.1%
- 6 TRTrupanion, Inc. TRUP 5.1%
- 7 PEPetMed Express, Inc. PETS 5.0%
- 8 PET VALU HOLDINGS LTD 4.8%
- 9 CVS GROUP PLC 4.7%
- 10 NESTLE SA-REG 4.4%
Positions in the fund: 28. The ten largest make up 72% of it.
Composition as of Nov 14, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 45%
- Consumer cyclical 24%
- Consumer defensive 20%
- Financials 7.3%
- Basic materials 3.4%
By country
- United States 66%
- United Kingdom 9.7%
- France 7.3%
- Canada 4.8%
- Other countries 12%
By company size
- Mega cap 5.6%
- Large cap 41%
- Mid cap 31%
- Small cap 15%
- Micro cap 7.0%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M. Counted from the companies that make up 71% of the fund.
Largest sector: Healthcare (45%). Largest country: United States (66%). Largest size group: Large cap (41%).
What does it cost me?
Expensive- A year from $10,000
- $50.00
- Over 20 years
- $2,416
From every $10,000 invested the fund takes $50.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,416.
How has it done?
Losing value- A year on average, 5 years
- -7.4%
- Deepest drop
- -51%
- Yearly volatility
- 18%
Average yearly decline over the last five years: 7.4%. Deepest drop in these years: 51% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 0.68%
- Payments a year
- 4
- Last payment
- $0.06
Over the last 12 months it paid $0.36 per share, which is 0.68% of today's price. The last payment was $0.06 on Sep 23, 2026.
Is it easy to buy and sell?
It trades little- Traded a day
- $110.1K
- Shares a day
- 2.1K
On an average day about $110.1K of the fund changes hands.
How expensive are the companies inside?
Rather expensive- P/E of the companies inside
- 26.3
- Average Bulios Score
- 64 out of 100
Weight by Bulios Fair Price
- Undervalued 31%
- Fairly valued 12%
- Overvalued 57%
On average the companies inside trade for 26.3 times their yearly profit. By Fair Price, 57% of the rated weight comes out as overvalued.
Counted from its largest companies (18), which make up 71% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.